A Follow-on Study of the Long-Term Safety of Aripiprazole in Patients With Chronic Schizophrenia

NCT02435836 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

631

Enrollment

INDUSTRY

Sponsor class

Stopped Study terminated when aripiprazole available commercially per protocol

Conditions

Schizophrenia

Interventions

DRUG: Aripiprazole

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.